Apixaban Patent Expiration
Apixaban is Used for reducing the risk of stroke and systemic embolism. It was first introduced by Bristol Myers Squibb Co Pharmaceutical Research Institute
Apixaban Patents
Given below is the list of patents protecting Apixaban, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Eliquis | US6413980 | Nitrogen containing heterobicycles as factor Xa inhibitors |
Dec 22, 2019
(Expired) | Bristol Myers Squibb |
| Eliquis | US6967208 | Lactam-containing compounds and derivatives thereof as factor Xa inhibitors | Nov 21, 2026 | Bristol Myers Squibb |
| Eliquis | US9326945 | Apixaban formulations | Feb 24, 2031 | Bristol Myers Squibb |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Apixaban Generics
Several generic applications have been filed for Apixaban. The first generic version for Apixaban was by Mylan Pharmaceuticals Inc and was approved on Dec 23, 2019. And the latest generic version is by Apotex Inc and was approved on Feb 16, 2024.
Given below is the list of companies who have filed for Apixaban generic.
1. ACCORD HLTHCARE
Accord Healthcare Inc has filed for 2 different strengths of generic version for Apixaban. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG | tablet | Prescription | ORAL | AB | Jul 28, 2020 |
| 5MG | tablet | Prescription | ORAL | AB | Jul 28, 2020 |
2. MYLAN
Mylan Pharmaceuticals Inc has filed for 2 different strengths of generic version for Apixaban. Given below are the details of the strengths of this generic introduced by Mylan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Discontinued | ORAL | N/A | Dec 23, 2019 |
| 2.5MG | tablet | Discontinued | ORAL | N/A | Dec 23, 2019 |
3. BIONPHARMA
Bionpharma Inc has filed for 2 different strengths of generic version for Apixaban. Given below are the details of the strengths of this generic introduced by Bionpharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Discontinued | ORAL | N/A | Apr 8, 2020 |
| 2.5MG | tablet | Discontinued | ORAL | N/A | Apr 8, 2020 |
4. MICRO LABS
Micro Labs Ltd has filed for 2 different strengths of generic version for Apixaban. Given below are the details of the strengths of this generic introduced by Micro Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG | tablet | Discontinued | ORAL | N/A | Dec 23, 2019 |
| 5MG | tablet | Discontinued | ORAL | N/A | Dec 23, 2019 |
5. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Apixaban. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Discontinued | ORAL | N/A | May 26, 2023 |
| 2.5MG | tablet | Discontinued | ORAL | N/A | May 26, 2023 |
6. HETERO LABS LTD V
Hetero Labs Ltd Unit V has filed for 2 different strengths of generic version for Apixaban. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd V.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Prescription | ORAL | AB | Nov 21, 2023 |
| 2.5MG | tablet | Prescription | ORAL | AB | Nov 21, 2023 |
7. BRECKENRIDGE
Breckenridge Pharmaceutical Inc has filed for 2 different strengths of generic version for Apixaban. Given below are the details of the strengths of this generic introduced by Breckenridge.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG | tablet | Discontinued | ORAL | N/A | Jul 26, 2021 |
| 5MG | tablet | Discontinued | ORAL | N/A | Jul 26, 2021 |
8. INDOCO
Indoco Remedies Ltd has filed for 2 different strengths of generic version for Apixaban. Given below are the details of the strengths of this generic introduced by Indoco.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG | tablet | Prescription | ORAL | AB | Sep 11, 2020 |
| 5MG | tablet | Prescription | ORAL | AB | Sep 11, 2020 |
9. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Apixaban. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Discontinued | ORAL | N/A | Feb 27, 2023 |
| 2.5MG | tablet | Discontinued | ORAL | N/A | Feb 27, 2023 |
10. APOTEX
Apotex Inc has filed for 2 different strengths of generic version for Apixaban. Given below are the details of the strengths of this generic introduced by Apotex.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG | tablet | Discontinued | ORAL | N/A | Feb 16, 2024 |
| 5MG | tablet | Discontinued | ORAL | N/A | Feb 16, 2024 |